• Neurosurgery

• Pituitary

The research focus of Adam N. Mamelak, MD, is pituitary tumor and endoscopic skull base surgery technical development. He is developing and testing new equipment and methods for minimally invasive surgery of pituitary and skull base tumors, and studying the pathogenesis of these tumors. He is also interested in neural basis of learning and memory through studying the neuro-physiological basis of memory processes in patients with implanted electrodes for identification of seizures or undergoing deep brain stimulation. Mamelak is looking into fluorescent guided removal of brain tumors.

View NIH Biographical Sketch as a PDF

• Medical School: Harvard School of Medicine, 1990
• Fellowship: University of California, San Francisco Medical Center, 1995
• Residency: University of California, San Francisco Medical Center, 1996
• Post Doctorate: California Institute of Technology, 1997

View CV as a PDF

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Brain Tumor Center (Johnnie L. Cochran, Jr. Brain Tumor Center)
• Movement Disorders
• Department of Neurology and Neurosurgery
• Epilepsy
• Parkinson's Disease Center
• Pituitary Center
• Cancer
• Neurosurgery

• Best Doctors, 2011-present
• Patient Choice Most Compassionate Doctor Award, 2009-present
• Member, Pituitary Society, 2007-present
• Member, International Society of Pituitary Surgeons, 2007-present
• Top Doctor in Neurological Surgery & Cancer, Castle Connolly, 2000-present

Click here for a list of peer-reviewed publications.

• Babu H, Ortega A, Nuno M, Dehgan A, Schweitzer A, Bonert V, Carmichael JD, Cooper O, Melmed S, Mamelak AN. Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors. Neurosurgery: 2017;00:1-10.
• Mamelak AN, Dowd CF, Tyrrell JB, McDonald JF, Wilson CB. Venous angiography is needed to interpret inferior petrosal sinus and cavernous sinus sampling data for lateralizing adrenocorticotropin-secreting adenomas. J Clin Endocrinol Metab. 1996;81(2):475-481.
• Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. 2006;24(22):3644-3650.